Advertisement
Screener

ZOGENIX, INC. Research and Development in Process

ZOGENIX, INC. Research and Development in Process

ZOGENIX, INC. reported Research and Development in Process of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.

Discontinued › Notes

us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-03-01

  • ZOGENIX, INC. research and development in process for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • ZOGENIX, INC. research and development in process for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
  • ZOGENIX, INC. research and development in process for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
  • ZOGENIX, INC. research and development in process for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
  • ZOGENIX, INC. research and development in process for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • ZOGENIX, INC. research and development in process for fiscal 2020 was $10.70M, a 95.74% decline from fiscal 2019.
  • ZOGENIX, INC. research and development in process for fiscal 2019 was $251.44M.
  • ZOGENIX, INC. research and development in process for fiscal 2018 was $0.00.
Period endResearch and Development in Process 3 monthResearch and Development in Process 6 monthResearch and Development in Process 9 monthResearch and Development in Process 12 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
10-K · filed 2022-03-01
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$0.00
derived: sum of 2 quarters · filed 2021-11-08
$0.00
10-Q · filed 2021-11-08
$6.20M
derived: sum of 4 quarters · filed 2022-03-01
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$0.00
10-Q · filed 2021-08-05
$6.20M
derived: sum of 3 quarters · filed 2022-03-01
$7.70M
derived: sum of 4 quarters · filed 2022-03-01
2021-03-31$0.00
10-Q · filed 2021-05-06
$6.20M
derived: sum of 2 quarters · filed 2022-03-01
$7.70M
derived: sum of 3 quarters · filed 2022-03-01
$9.20M
derived: sum of 4 quarters · filed 2022-03-01
2020-12-31$6.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$7.70M
derived: sum of 2 quarters · filed 2022-03-01
$9.20M
derived: sum of 3 quarters · filed 2022-03-01
$10.70M
10-K · filed 2022-03-01
2020-09-30$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$3.00M
derived: sum of 2 quarters · filed 2021-11-08
$4.50M
10-Q · filed 2021-11-08
$6.50M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$1.50M
10-Q · filed 2020-08-06
$3.00M
10-Q · filed 2021-08-05
$5.00M
derived: sum of 3 quarters · filed 2022-03-01
$254.44M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$1.50M
10-Q · filed 2021-05-06
$3.50M
derived: sum of 2 quarters · filed 2022-03-01
$252.94M
derived: sum of 3 quarters · filed 2022-03-01
$252.94M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$251.44M
derived: sum of 2 quarters · filed 2022-03-01
$251.44M
derived: sum of 3 quarters · filed 2022-03-01
$251.44M
10-K · filed 2022-03-01
2019-09-30$249.44M
10-Q · filed 2019-11-07
$249.44M
derived: sum of 2 quarters · filed 2020-08-06
$249.44M
10-Q · filed 2020-11-09
$249.44M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$0.00
10-Q · filed 2020-08-06
$0.00
10-Q · filed 2020-08-06
$0.00
derived: sum of 3 quarters · filed 2021-03-01
$0.00
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$0.00
10-Q · filed 2020-05-06
$0.00
derived: sum of 2 quarters · filed 2021-03-01
$0.00
derived: sum of 3 quarters · filed 2021-03-01
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$0.00
derived: sum of 2 quarters · filed 2021-03-01
$0.00
10-K · filed 2021-03-01
2018-09-30$0.00
10-Q · filed 2019-11-07
$0.00
10-Q · filed 2019-11-07
2017-12-31$0.00
10-K · filed 2020-03-02